-
For low back pain management, the usual care recommended by general practitioners does not follow evidence-based guidelines and does not provide best outcomes; this has not improved over time.
-
Adding a muscle relaxer to an NSAID added no benefit in acute neck strain.
-
The FDA has approved a potassium channel blocker to improve walking in adults with multiple sclerosis.
-
Nonspecific chest pain is a persistent illness and patients with it are subject to overly extensive work-ups.
-
For women with suspected urinary tract infection, there is no advantage to routinely sending midstream urine samples for testing; antibiotics based on dipstick tests with a delayed prescription as backup, or empirical delayed prescription, can help to reduce antibiotic use.
-
Staging of chronic kidney disease (CKD) is based primarily upon estimated GFR. Proteinuria (PRO) is a strong marker for kidney disease, yet its severity is not included in current risk stratification schemes, which are instead driven by GFR.
-
Even in people who had never smoked cigarettes, pipe and cigar smoking was associated with decreased lung function and increased odds of airflow obstruction.
-
Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions
-
A second human glucagon-like peptide 1 (glp-1) analog/receptor agonist has been approved by the FDA for the treatment of type 2 diabetes mellitus (DM2).
-
About a third of patients with sleep apnea have chronic cough. Such patients are more likely to be women and to have heartburn and rhinitis.